LOS ANGELES--(BUSINESS WIRE)--In classic Las Vegas fashion, with red-feathered showgirls and an Elvis impersonator entertaining the crowds, MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) opened its first branded store in the tourist mecca and entertainment capital of the world.
Located at 823 3rd Street in the Arts District and near the Fremont Street Experience, MedMen Downtown Las Vegas is the Company’s 14th store nationwide. MedMen has been operating a second dispensary in North Las Vegas, which won approval last month to move to 4503 Paradise Road near the Hard Rock Hotel, the Thomas and Mack Center and McCarran International Airport. MedMen Las Vegas Airport is currently under construction.
“We’re excited to put an anchor here in Downtown Las Vegas. Nevada is setting an example for the world,” said MedMen CEO Adam Bierman during a ribbon-cutting ceremony attended by local dignitaries and a crowd of onlookers awaiting to enter the store. “This is just the beginning.”
Nevada State Senator Tick Segerblom, a longtime advocate for marijuana legalization, was in attendance. “We are so excited to have MedMen here in Downtown Las Vegas,” said Segerblom. “They are the premiere brand in the world and we can’t thank them enough for coming here.”
Las Vegas City Councilwoman Michele Fiore said, “MedMen is raising the bar. This is not a pot shop. This is a retail store that shatters stereotypes. This is the future of cannabis.”
Las Vegas ranks as one of the world’s most visited tourist destinations, with an average 40 million visitors annually. The historic center of Las Vegas and the original gambling district, the city’s downtown area has been going through a much-touted renaissance in recent years.
Nevada also is one of the fastest growing state-sanctioned marijuana markets in the country. According to the Nevada Department of Taxation, cannabis accounted for about $386 million of the total statewide taxable sales for the period of July 2017 through March 2018, about 19.3 percent of the state’s growth in taxable sales compared to the same period last year.
A leading cultivator, producer and retailer of state-sanctioned cannabis in the U.S., MedMen currently operates licensed facilities in California, Nevada and New York.
MedMen Enterprises is the preeminent cannabis company in the U.S. with assets and operations nationwide. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. Visit http://www.medmen.com
Source: MedMen Enterprises
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the timing of the opening of new stores in Las Vegas and plans for additional stores in Las Vegas.
By identifying such information and statements in this manner, MedMen is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedMen to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, MedMen has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: adverse changes in the public perception of cannabis; changes in consumer demand for cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets in which the Company operates; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; increasing costs of compliance with extensive government regulation; changes in general economic, business and political conditions, including changes in the financial markets and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; risks related to licensing, including the ability to obtain the requisite licenses or renew existing licenses for the Company’s proposed operations; dependence upon third party service providers skilled labor and key inputs for purposes for example facility design and construction activities; risks inherent in the agricultural business; intellectual property risks; risks related to litigation; dependence upon senior management. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although MedMen believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to MedMen or persons acting on its behalf is expressly qualified in its entirety by this notice.